Internal Medicine, Gastroenterology · Orlando, FL
NPI
1932148285
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1817 N Mills Ave
Orlando, FL, 32803
Phone (407) 896-1726
Groups this clinician bills Medicare through
Medicare paid, 2024
$186K
6,831 services
Medicare patients, 2024
943
Average age 74
Drug cost, 2024
$2.9M
1,541 prescriptions
Company payments, 2025
$1,445
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Henry Levine was code 99213 (office e&m - established), 342 times for 320 patients. In total Henry Levine billed 6,831 services in 36 codes, and Medicare paid $186K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 342 | 320 | $62.13 | $21K |
| 99214 Office E&M - Established | Office | 218 | 196 | $90.98 | $20K |
| 43239 Upper GI Endoscopy | Facility | 190 | 187 | $63.49 | $12K |
| 99203 Office E&M - New | Office | 136 | 136 | $70.54 | $9,593 |
| 45385 Colonoscopy - Lesion Removal | Facility | 133 | 132 | $202.39 | $27K |
| 45380 Lower GI Endoscopy - Other | Facility | 125 | 124 | $116.21 | $15K |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 113 | 112 | $178.19 | $20K |
| 45378 Lower GI Endoscopy - Other | Facility | 69 | 68 | $117.46 | $8,105 |
| 99204 Office E&M - New | Office | 48 | 48 | $117.62 | $5,646 |
| 76981 Ultrasound - Nonspecific | Office | 46 | 45 | $71.23 | $3,277 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 41 | 41 | $180.62 | $7,406 |
| 96413 Chemotherapy Administration | Office | 31 | 12 | $86.38 | $2,678 |
| 43249 Upper GI Endoscopy | Facility | 27 | 24 | $106.68 | $2,880 |
| 91110 Standard X-ray | Office | 13 | 11 | $516.61 | $6,716 |
By year: 2022 $267K for 7,908 services; 2023 $201K for 2,665 services; 2024 $186K for 6,831 services.
Medicare prescription drug claims, 2024
In 2024, the drug Henry Levine prescribed most often to Medicare patients was Gavilyte-G (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 335 prescriptions and refills. In total Henry Levine wrote 1,541 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 335 | 335 | 318 | $4,893 |
| Omeprazole Generic | 226 | 524 | 94 | $2,593 |
| Pantoprazole Sodium Generic | 174 | 410 | 73 | $2,663 |
| Dicyclomine Hcl Generic | 68 | 76 | 34 | $766 |
| Skyrizi On-Body Risankizumab-Rzaa | 58 | 90 | 11 | $1.2M |
| Famotidine Generic | 42 | 120 | 21 | $756 |
| Creon Lipase/Protease/Amylase | 42 | 60 | Under 11 | $156K |
| Esomeprazole Magnesium Generic | 38 | 82 | 16 | $985 |
| Dexlansoprazole Dr Dexlansoprazole | 28 | 68 | 15 | $10,000 |
| Budesonide Dr Budesonide | 28 | 46 | Under 11 | $2,530 |
| Megestrol Acetate Generic | 26 | 26 | Under 11 | $1,067 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 24 | 24 | 22 | $437 |
| Rezdiffra Resmetirom | 20 | 20 | Under 11 | $75K |
| Sucralfate Generic | 19 | 24 | Under 11 | $520 |
| Mesalamine Er Mesalamine | 18 | 36 | Under 11 | $1,883 |
Brand drugs: 337 claims; generic drugs: 1,204 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Henry Levine $1,445 ($1,445 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $491.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $491 |
| Madrigal Pharmaceuticals MDGL | 13 | $277 |
| Janssen Biotech, Inc. JNJ | 5 | $199 |
| Celltrion USA Inc. 068270.KS | 2 | $134 |
| Enterra Medical, Inc. | 1 | $122 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 3 | $62.98 |
| Genzyme Corporation SNY | 2 | $43.78 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $38.96 |
| Novo Nordisk Inc NVO | 2 | $32.49 |
| CapsoVision, Inc. CV | 1 | $29.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.